Amgen Inc. Profile Avatar - Palmy Investing

Amgen Inc.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to tr…
Drug Manufacturers - General
US, Thousand Oaks [HQ]

News

Theses · Events · Sentiments
Sentiments
24-11-13 -3.40%

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a …

24-11-13 0.00%

THOUSAND OAKS, Calif. , Nov. 13, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement on the MariTide (maridebart …

End of AMGN's Analysis
CIK: 318154 CUSIP: 031162100 ISIN: US0311621009 LEI: - UEI: -
Secondary Listings